Versant Venture Management, LLC Veracyte, Inc. Transaction History

Versant Venture Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$26.73 - $35.67 $32.2 Million - $43 Million	-1,205,407 Closed	0 $0
Q3 2019 Oct 08, 2019	SELL	$23.87 - $30.93 $28.8 Million - $37.3 Million	-1,205,408 Reduced 50.0%	1,205,407 $28.9 Billion
Q2 2019 Jul 12, 2019	SELL	$22.1 - $28.56 $26.6 Million - $34.4 Million	-1,205,406 Reduced 33.33%	2,410,815 $68.7 Billion
Q3 2018 Oct 05, 2018	BUY	$9.55 - $12.64 $34.5 Million - $45.7 Million	3,616,221 New	3,616,221 $34.5 Billion

308

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.83B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Versant Venture Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Versant Venture Management, LLC with notifications on news.